CTx-1301 Dexmethylphenidate: FDA Review & ADHD Clinical Data
Explore the clinical data and 505(b)(2) FDA regulatory pathway for CTx-1301 (dexmethylphenidate), a novel once-daily stimulant candidate for ADHD treatment.
Back to Articles
Articles tagged with “stimulant-therapy”